Determining the axillary nodal status with four current imaging modalities including 18 F-FDG PET/MRI in newly diagnosed breast cancer: A comparative study using histopathology as reference standard

To compare breast magnetic resonance imaging (MRI), thoracal MRI, thoracal F-fluorodeoxyglucose positron emission tomography ( F-FDG PET)/MRI and axillary sonography for the detection of axillary lymph node metastases in women with newly diagnosed breast cancer. This prospective double-center study...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of nuclear medicine (1978) 2021-05
Hauptverfasser: Morawitz, Janna, Bruckmann, Nils-Martin, Dietzel, Frederic, Ullrich, Tim, Bittner, Ann-Kathrin, Hoffmann, Oliver, Mohrmann, Svjetlana, Haeberle, Lena, Ingenwerth, Marc, Umutlu, Lale, Fendler, Wolfgang Peter, Fehm, Tanja, Herrmann, Ken, Antoch, Gerald, Sawicki, Lino Morris, Kirchner, Julian
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title The Journal of nuclear medicine (1978)
container_volume
creator Morawitz, Janna
Bruckmann, Nils-Martin
Dietzel, Frederic
Ullrich, Tim
Bittner, Ann-Kathrin
Hoffmann, Oliver
Mohrmann, Svjetlana
Haeberle, Lena
Ingenwerth, Marc
Umutlu, Lale
Fendler, Wolfgang Peter
Fehm, Tanja
Herrmann, Ken
Antoch, Gerald
Sawicki, Lino Morris
Kirchner, Julian
description To compare breast magnetic resonance imaging (MRI), thoracal MRI, thoracal F-fluorodeoxyglucose positron emission tomography ( F-FDG PET)/MRI and axillary sonography for the detection of axillary lymph node metastases in women with newly diagnosed breast cancer. This prospective double-center study included patients with newly diagnosed breast cancer between March 2018 and December 2019. Patients underwent thoracal ( F-FDG PET/)MRI, axillary sonography, and dedicated prone breast MRI. Datasets were evaluated separately regarding nodal status (nodal+ vs. nodal-). Histopathology served as reference standard in all patients. The diagnostic performance of breast MRI, thoracal MRI, thoracal PET/MRI and axillary sonography in detecting nodal positive patients was tested by creating receiver-operating-characteristic curves (ROC) with a calculated area under the curve (AUC). Sensitivity, specificity, positive predictive value, negative predictive value, and accuracy were calculated for all four modalities. A McNemar test was used to assess differences. 112 female patients (mean age 53.04 ± 12.6 years) were evaluated. Thoracal PET/MRI showed the highest ROC-AUC with a value of 0.892. The AUC for breast MRI, thoracal MRI and sonography were 0.782, 0.814 and 0.834, respectively. Differences between thoracal PET/MRI and axillary sonography, thoracal MRI and breast MRI were statistically significant (PET/MRI vs. axillary sonography, = 0.01; PET/MRI vs. thoracal MRI, = 0.02; PET/MRI vs. breast MRI, = 0.03). PET/MRI showed the highest sensitivity (81.8%, 36/44) (95%-CI: 67.29-91.81%) while axillary sonography had the highest specificity (98.5%, 65/66), 95%-CI: 91.84-99.96%). F-FDG PET/MRI outperforms axillary sonography, breast MRI and thoracal MRI in determining the axillary lymph node status. In a clinical setting, the combination of F-FDG PET/MRI and axillary sonography might be considered to provide even more accuracy in diagnosis.
doi_str_mv 10.2967/jnumed.121.262009
format Article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_34016726</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>34016726</sourcerecordid><originalsourceid>FETCH-pubmed_primary_340167263</originalsourceid><addsrcrecordid>eNqFkE1Ow0AMhUdIiJafA7BBvkDbSUKmKTtEG2CBhFD3lZtxk6kmM9H8UHJBzkUiwZqVpefPz89m7Dbh83QlloujiS3JeZIm81SknK_O2DTJs3yWC7GcsEvvj5xzURTFBZtk9zwRy1RM2feaArlWGWVqCA0Bfimt0fVgrEQNPmCIHk4qNHCw0UEVnSMTQLVYjzPtiKmgyIMylY5yFJMCylm5fob3zXbx9vE6tMDQSfcgFdbGepKwd4Q-QIWmIvcAj1DZtkOHQX3SsDbKHqIfzRrlg-0wNFbbugf04OhAQ4hq5NBIdPKanR9Qe7r5rVfsrtxsn15mXdwPb9l1bsjr-t3f4dm_wA_v0G45</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Determining the axillary nodal status with four current imaging modalities including 18 F-FDG PET/MRI in newly diagnosed breast cancer: A comparative study using histopathology as reference standard</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Morawitz, Janna ; Bruckmann, Nils-Martin ; Dietzel, Frederic ; Ullrich, Tim ; Bittner, Ann-Kathrin ; Hoffmann, Oliver ; Mohrmann, Svjetlana ; Haeberle, Lena ; Ingenwerth, Marc ; Umutlu, Lale ; Fendler, Wolfgang Peter ; Fehm, Tanja ; Herrmann, Ken ; Antoch, Gerald ; Sawicki, Lino Morris ; Kirchner, Julian</creator><creatorcontrib>Morawitz, Janna ; Bruckmann, Nils-Martin ; Dietzel, Frederic ; Ullrich, Tim ; Bittner, Ann-Kathrin ; Hoffmann, Oliver ; Mohrmann, Svjetlana ; Haeberle, Lena ; Ingenwerth, Marc ; Umutlu, Lale ; Fendler, Wolfgang Peter ; Fehm, Tanja ; Herrmann, Ken ; Antoch, Gerald ; Sawicki, Lino Morris ; Kirchner, Julian</creatorcontrib><description>To compare breast magnetic resonance imaging (MRI), thoracal MRI, thoracal F-fluorodeoxyglucose positron emission tomography ( F-FDG PET)/MRI and axillary sonography for the detection of axillary lymph node metastases in women with newly diagnosed breast cancer. This prospective double-center study included patients with newly diagnosed breast cancer between March 2018 and December 2019. Patients underwent thoracal ( F-FDG PET/)MRI, axillary sonography, and dedicated prone breast MRI. Datasets were evaluated separately regarding nodal status (nodal+ vs. nodal-). Histopathology served as reference standard in all patients. The diagnostic performance of breast MRI, thoracal MRI, thoracal PET/MRI and axillary sonography in detecting nodal positive patients was tested by creating receiver-operating-characteristic curves (ROC) with a calculated area under the curve (AUC). Sensitivity, specificity, positive predictive value, negative predictive value, and accuracy were calculated for all four modalities. A McNemar test was used to assess differences. 112 female patients (mean age 53.04 ± 12.6 years) were evaluated. Thoracal PET/MRI showed the highest ROC-AUC with a value of 0.892. The AUC for breast MRI, thoracal MRI and sonography were 0.782, 0.814 and 0.834, respectively. Differences between thoracal PET/MRI and axillary sonography, thoracal MRI and breast MRI were statistically significant (PET/MRI vs. axillary sonography, = 0.01; PET/MRI vs. thoracal MRI, = 0.02; PET/MRI vs. breast MRI, = 0.03). PET/MRI showed the highest sensitivity (81.8%, 36/44) (95%-CI: 67.29-91.81%) while axillary sonography had the highest specificity (98.5%, 65/66), 95%-CI: 91.84-99.96%). F-FDG PET/MRI outperforms axillary sonography, breast MRI and thoracal MRI in determining the axillary lymph node status. In a clinical setting, the combination of F-FDG PET/MRI and axillary sonography might be considered to provide even more accuracy in diagnosis.</description><identifier>EISSN: 1535-5667</identifier><identifier>DOI: 10.2967/jnumed.121.262009</identifier><identifier>PMID: 34016726</identifier><language>eng</language><publisher>United States</publisher><ispartof>The Journal of nuclear medicine (1978), 2021-05</ispartof><rights>Copyright © 2021 by the Society of Nuclear Medicine and Molecular Imaging, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0001-6694-247X ; 0000-0002-5106-3584 ; 0000-0002-8982-5601</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34016726$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Morawitz, Janna</creatorcontrib><creatorcontrib>Bruckmann, Nils-Martin</creatorcontrib><creatorcontrib>Dietzel, Frederic</creatorcontrib><creatorcontrib>Ullrich, Tim</creatorcontrib><creatorcontrib>Bittner, Ann-Kathrin</creatorcontrib><creatorcontrib>Hoffmann, Oliver</creatorcontrib><creatorcontrib>Mohrmann, Svjetlana</creatorcontrib><creatorcontrib>Haeberle, Lena</creatorcontrib><creatorcontrib>Ingenwerth, Marc</creatorcontrib><creatorcontrib>Umutlu, Lale</creatorcontrib><creatorcontrib>Fendler, Wolfgang Peter</creatorcontrib><creatorcontrib>Fehm, Tanja</creatorcontrib><creatorcontrib>Herrmann, Ken</creatorcontrib><creatorcontrib>Antoch, Gerald</creatorcontrib><creatorcontrib>Sawicki, Lino Morris</creatorcontrib><creatorcontrib>Kirchner, Julian</creatorcontrib><title>Determining the axillary nodal status with four current imaging modalities including 18 F-FDG PET/MRI in newly diagnosed breast cancer: A comparative study using histopathology as reference standard</title><title>The Journal of nuclear medicine (1978)</title><addtitle>J Nucl Med</addtitle><description>To compare breast magnetic resonance imaging (MRI), thoracal MRI, thoracal F-fluorodeoxyglucose positron emission tomography ( F-FDG PET)/MRI and axillary sonography for the detection of axillary lymph node metastases in women with newly diagnosed breast cancer. This prospective double-center study included patients with newly diagnosed breast cancer between March 2018 and December 2019. Patients underwent thoracal ( F-FDG PET/)MRI, axillary sonography, and dedicated prone breast MRI. Datasets were evaluated separately regarding nodal status (nodal+ vs. nodal-). Histopathology served as reference standard in all patients. The diagnostic performance of breast MRI, thoracal MRI, thoracal PET/MRI and axillary sonography in detecting nodal positive patients was tested by creating receiver-operating-characteristic curves (ROC) with a calculated area under the curve (AUC). Sensitivity, specificity, positive predictive value, negative predictive value, and accuracy were calculated for all four modalities. A McNemar test was used to assess differences. 112 female patients (mean age 53.04 ± 12.6 years) were evaluated. Thoracal PET/MRI showed the highest ROC-AUC with a value of 0.892. The AUC for breast MRI, thoracal MRI and sonography were 0.782, 0.814 and 0.834, respectively. Differences between thoracal PET/MRI and axillary sonography, thoracal MRI and breast MRI were statistically significant (PET/MRI vs. axillary sonography, = 0.01; PET/MRI vs. thoracal MRI, = 0.02; PET/MRI vs. breast MRI, = 0.03). PET/MRI showed the highest sensitivity (81.8%, 36/44) (95%-CI: 67.29-91.81%) while axillary sonography had the highest specificity (98.5%, 65/66), 95%-CI: 91.84-99.96%). F-FDG PET/MRI outperforms axillary sonography, breast MRI and thoracal MRI in determining the axillary lymph node status. In a clinical setting, the combination of F-FDG PET/MRI and axillary sonography might be considered to provide even more accuracy in diagnosis.</description><issn>1535-5667</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNqFkE1Ow0AMhUdIiJafA7BBvkDbSUKmKTtEG2CBhFD3lZtxk6kmM9H8UHJBzkUiwZqVpefPz89m7Dbh83QlloujiS3JeZIm81SknK_O2DTJs3yWC7GcsEvvj5xzURTFBZtk9zwRy1RM2feaArlWGWVqCA0Bfimt0fVgrEQNPmCIHk4qNHCw0UEVnSMTQLVYjzPtiKmgyIMylY5yFJMCylm5fob3zXbx9vE6tMDQSfcgFdbGepKwd4Q-QIWmIvcAj1DZtkOHQX3SsDbKHqIfzRrlg-0wNFbbugf04OhAQ4hq5NBIdPKanR9Qe7r5rVfsrtxsn15mXdwPb9l1bsjr-t3f4dm_wA_v0G45</recordid><startdate>20210520</startdate><enddate>20210520</enddate><creator>Morawitz, Janna</creator><creator>Bruckmann, Nils-Martin</creator><creator>Dietzel, Frederic</creator><creator>Ullrich, Tim</creator><creator>Bittner, Ann-Kathrin</creator><creator>Hoffmann, Oliver</creator><creator>Mohrmann, Svjetlana</creator><creator>Haeberle, Lena</creator><creator>Ingenwerth, Marc</creator><creator>Umutlu, Lale</creator><creator>Fendler, Wolfgang Peter</creator><creator>Fehm, Tanja</creator><creator>Herrmann, Ken</creator><creator>Antoch, Gerald</creator><creator>Sawicki, Lino Morris</creator><creator>Kirchner, Julian</creator><scope>NPM</scope><orcidid>https://orcid.org/0000-0001-6694-247X</orcidid><orcidid>https://orcid.org/0000-0002-5106-3584</orcidid><orcidid>https://orcid.org/0000-0002-8982-5601</orcidid></search><sort><creationdate>20210520</creationdate><title>Determining the axillary nodal status with four current imaging modalities including 18 F-FDG PET/MRI in newly diagnosed breast cancer: A comparative study using histopathology as reference standard</title><author>Morawitz, Janna ; Bruckmann, Nils-Martin ; Dietzel, Frederic ; Ullrich, Tim ; Bittner, Ann-Kathrin ; Hoffmann, Oliver ; Mohrmann, Svjetlana ; Haeberle, Lena ; Ingenwerth, Marc ; Umutlu, Lale ; Fendler, Wolfgang Peter ; Fehm, Tanja ; Herrmann, Ken ; Antoch, Gerald ; Sawicki, Lino Morris ; Kirchner, Julian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmed_primary_340167263</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Morawitz, Janna</creatorcontrib><creatorcontrib>Bruckmann, Nils-Martin</creatorcontrib><creatorcontrib>Dietzel, Frederic</creatorcontrib><creatorcontrib>Ullrich, Tim</creatorcontrib><creatorcontrib>Bittner, Ann-Kathrin</creatorcontrib><creatorcontrib>Hoffmann, Oliver</creatorcontrib><creatorcontrib>Mohrmann, Svjetlana</creatorcontrib><creatorcontrib>Haeberle, Lena</creatorcontrib><creatorcontrib>Ingenwerth, Marc</creatorcontrib><creatorcontrib>Umutlu, Lale</creatorcontrib><creatorcontrib>Fendler, Wolfgang Peter</creatorcontrib><creatorcontrib>Fehm, Tanja</creatorcontrib><creatorcontrib>Herrmann, Ken</creatorcontrib><creatorcontrib>Antoch, Gerald</creatorcontrib><creatorcontrib>Sawicki, Lino Morris</creatorcontrib><creatorcontrib>Kirchner, Julian</creatorcontrib><collection>PubMed</collection><jtitle>The Journal of nuclear medicine (1978)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Morawitz, Janna</au><au>Bruckmann, Nils-Martin</au><au>Dietzel, Frederic</au><au>Ullrich, Tim</au><au>Bittner, Ann-Kathrin</au><au>Hoffmann, Oliver</au><au>Mohrmann, Svjetlana</au><au>Haeberle, Lena</au><au>Ingenwerth, Marc</au><au>Umutlu, Lale</au><au>Fendler, Wolfgang Peter</au><au>Fehm, Tanja</au><au>Herrmann, Ken</au><au>Antoch, Gerald</au><au>Sawicki, Lino Morris</au><au>Kirchner, Julian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Determining the axillary nodal status with four current imaging modalities including 18 F-FDG PET/MRI in newly diagnosed breast cancer: A comparative study using histopathology as reference standard</atitle><jtitle>The Journal of nuclear medicine (1978)</jtitle><addtitle>J Nucl Med</addtitle><date>2021-05-20</date><risdate>2021</risdate><eissn>1535-5667</eissn><abstract>To compare breast magnetic resonance imaging (MRI), thoracal MRI, thoracal F-fluorodeoxyglucose positron emission tomography ( F-FDG PET)/MRI and axillary sonography for the detection of axillary lymph node metastases in women with newly diagnosed breast cancer. This prospective double-center study included patients with newly diagnosed breast cancer between March 2018 and December 2019. Patients underwent thoracal ( F-FDG PET/)MRI, axillary sonography, and dedicated prone breast MRI. Datasets were evaluated separately regarding nodal status (nodal+ vs. nodal-). Histopathology served as reference standard in all patients. The diagnostic performance of breast MRI, thoracal MRI, thoracal PET/MRI and axillary sonography in detecting nodal positive patients was tested by creating receiver-operating-characteristic curves (ROC) with a calculated area under the curve (AUC). Sensitivity, specificity, positive predictive value, negative predictive value, and accuracy were calculated for all four modalities. A McNemar test was used to assess differences. 112 female patients (mean age 53.04 ± 12.6 years) were evaluated. Thoracal PET/MRI showed the highest ROC-AUC with a value of 0.892. The AUC for breast MRI, thoracal MRI and sonography were 0.782, 0.814 and 0.834, respectively. Differences between thoracal PET/MRI and axillary sonography, thoracal MRI and breast MRI were statistically significant (PET/MRI vs. axillary sonography, = 0.01; PET/MRI vs. thoracal MRI, = 0.02; PET/MRI vs. breast MRI, = 0.03). PET/MRI showed the highest sensitivity (81.8%, 36/44) (95%-CI: 67.29-91.81%) while axillary sonography had the highest specificity (98.5%, 65/66), 95%-CI: 91.84-99.96%). F-FDG PET/MRI outperforms axillary sonography, breast MRI and thoracal MRI in determining the axillary lymph node status. In a clinical setting, the combination of F-FDG PET/MRI and axillary sonography might be considered to provide even more accuracy in diagnosis.</abstract><cop>United States</cop><pmid>34016726</pmid><doi>10.2967/jnumed.121.262009</doi><orcidid>https://orcid.org/0000-0001-6694-247X</orcidid><orcidid>https://orcid.org/0000-0002-5106-3584</orcidid><orcidid>https://orcid.org/0000-0002-8982-5601</orcidid></addata></record>
fulltext fulltext
identifier EISSN: 1535-5667
ispartof The Journal of nuclear medicine (1978), 2021-05
issn 1535-5667
language eng
recordid cdi_pubmed_primary_34016726
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
title Determining the axillary nodal status with four current imaging modalities including 18 F-FDG PET/MRI in newly diagnosed breast cancer: A comparative study using histopathology as reference standard
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T01%3A29%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Determining%20the%20axillary%20nodal%20status%20with%20four%20current%20imaging%20modalities%20including%2018%20F-FDG%20PET/MRI%20in%20newly%20diagnosed%20breast%20cancer:%20A%20comparative%20study%20using%20histopathology%20as%20reference%20standard&rft.jtitle=The%20Journal%20of%20nuclear%20medicine%20(1978)&rft.au=Morawitz,%20Janna&rft.date=2021-05-20&rft.eissn=1535-5667&rft_id=info:doi/10.2967/jnumed.121.262009&rft_dat=%3Cpubmed%3E34016726%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/34016726&rfr_iscdi=true